Articles

Export 9 results:

Filters: Keyword is Dendritic cell [Clear All Filters]

2012

Zaccone P, Hall SW. 2012. Helminth Infection and Type 1 Diabetes. The Review of Diabetic Studies. 9(4):272-286.

PDF (851.53 KB)

Di Caro V, Giannoukakis N, Trucco M. 2012. In vivo Delivery of Nucleic Acid-Formulated Microparticles as a Potential Tolerogenic Vaccine for Type 1 Diabetes. The Review of Diabetic Studies. 9(4):348-356.

PDF (5.11 MB)

Petzold C, Schallenberg S, Stern JNH, Kretschmer K. 2012. Targeted Antigen Delivery to DEC-205+ Dendritic Cells for Tolerogenic Vaccination. The Review of Diabetic Studies. 9(4):305-318.

PDF (379 KB)

F Wong S, Wen L. 2012. Type 1 Diabetes Therapy Beyond T Cell Targeting: Monocytes, B Cells, and Innate Lymphocytes. The Review of Diabetic Studies. 9(4):289-304.

PDF (823.03 KB)

2010

Petzold C, Riewaldt J, Koenig T, Schallenberg S, Kretschmer K. 2010. Dendritic Cell-Targeted Pancreatic β-Cell Antigen Leads to Conversion of Self-Reactive CD4+ T Cells Into Regulatory T Cells and Promotes Immunotolerance in NOD Mice. The Review of Diabetic Studies. 7(1):47-61.

PDF (646.97 KB)

Sia C, Hänninen A. 2010. Functional Alterations of Proinflammatory Monocytes by T Regulatory Cells: Implications for the Prevention and Reversal of Type 1 Diabetes. The Review of Diabetic Studies. 7(1):6-14.

PDF (761.23 KB)

2009

Phillips JM, Parish NM, Raine T, Bland C, Sawyer Y, De La Peña H, Cooke A. 2009. Type 1 Diabetes Development Requires Both CD4+ and CD8+ T cells and Can Be Reversed by Non-Depleting Antibodies Targeting Both T Cell Populations. The Review of Diabetic Studies. 6(2):97-103.

RevDiabeticStud-6-2-97.pdf (231.34 KB)

Phillips JM, Parish NM, Raine T, Bland C, Sawyer Y, De La Peña H, Cooke A. 2009. Type 1 Diabetes Development Requires Both CD4+ and CD8+ T cells and Can Be Reversed by Non-Depleting Antibodies Targeting Both T Cell Populations. The Review of Diabetic Studies. 6(2):97-103.

PDF (231.34 KB)

2008

Maksimow M, Alam C, Hänninen A. 2008. Incomplete Killing And Enhanced Activation of Islet-Reactive CD8+ T Cells by FasL-Expressing Dendritic Cells Limits Protection from Diabetes. The Review of Diabetic Studies. 5(3):144-153.

PDF (531.39 KB)